Hi plumvj, interesting Imugene using Blincyto (blinatumomab) and CF33-CD19 in our OASIS study.
Durability of complete response (DOCR) after blinatumomab therapy for refractory/relapsed aggressive B-cell non-Hodgkin lymphoma.
https://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.e19041
Looking forward to a future Azer-cel / CF33-CD19 in house study.
Regards.
Hi plumvj, interesting Imugene using Blincyto (blinatumomab) and...
-
- There are more pages in this discussion • 2,559 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(3.64%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.3¢ | $405.8K | 7.459M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1284400 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 976369 | 18 |
View Market Depth
| Last trade - 14.27pm 12/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |